Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections.
Hurwitz SJ, De R, LeCher JC, Downs-Bowen JA, Goh SL, Zandi K, McBrayer T, Amblard F, Patel D, Kohler JJ, Bhasin M, Dobosh BS, Sukhatme V, Tirouvanziam RM, Schinazi RF.
Hurwitz SJ, et al. Among authors: patel d.
Viruses. 2024 Apr 22;16(4):651. doi: 10.3390/v16040651.
Viruses. 2024.
PMID: 38675992